Chloroquine Phosphate and Arbidol approved for trial as treatment for coronavirus 

Chloroquine Phosphate, an antimalarial drug along with another antiviral drug, Arbidol, have been approved on a trial basis for treating the novel coronavirus, according to an updated trial plan for the diagnosis and treatment of pneumonia caused by the virus, issued by the National Health Commission on Wednesday.

Earlier reports said several drugs, including Remdesivir, Chloroquine Phosphate and Fapilavir, have been screened and have shown good clinical efficacy in treating the novel coronavirus.

In the newly-published diagnosis and treatment plan, transmission through high concentrations of aerosol in confined spaces is possible. Aerosol, a suspension of fine solid or liquid particles in gas, can transmit the novel coronavirus if anyone is exposed to a high concentrated contaminated mixture in an enclosed area for an extended period.